Yahoo Finance • 17 days ago
In trading on Monday, shares of Hercules Technology Growth Capital (Symbol: HTGC) crossed below their 200 day moving average of $19.14, changing hands as low as $19.05 per share. Hercules Technology Growth Capital shares are currently tra... Full story
Yahoo Finance • 17 days ago
* uniQure (NASDAQ:QURE [https://seekingalpha.com/symbol/QURE]) said on Wednesday that it entered into a $175M non-dilutive senior secured term loan facility [https://seekingalpha.com/pr/20242480-uniqure-announces-refinancing-of-existing-... Full story
Yahoo Finance • 17 days ago
~ Term of current $50 million debt outstanding extended from January 2027 to October 2030 ~ ~ Additional $100 million available subject to regulatory and financial milestones ~ ~ Additional $25 million available subject to Hercules’ appr... Full story
Yahoo Finance • last month
We’re through the final turn of 2025, with the finish line already in sight. That makes now the perfect moment to zero in on stocks that can deliver returns as the holiday season approaches. The best portfolios rest on a diversified approa... Full story
Yahoo Finance • last month
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organ... Full story
Yahoo Finance • 2 months ago
Hercules Capital, Inc. (NYSE:HTGC), a leading player in the venture lending market with a market capitalization of $3.47 billion, has been demonstrating strong performance and positioning itself for continued growth in the dynamic landscap... Full story
Yahoo Finance • 2 months ago
Heron Therapeutics (HRTX) said Friday it has completed its capital restructuring to boost financial PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story
Yahoo Finance • 2 months ago
Investing.com - JMP Securities raised its price target on Hercules Capital Inc (NYSE:HTGC) to $24.00 from $22.00 on Monday, while maintaining a Market Outperform rating on the business development company. The new target falls within the b... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: Hercules Capital (HTGC) Q2 2025 MANAGEMENT VIEW * Scott Bluestein, CEO, highlighted "another strong quarter of record fundings and record operating performance," noting that Q2 marked the second consecutive quar... Full story
Yahoo Finance • 2 months ago
[BDC concept is shown by businessman.] 8vFanI/iStock via Getty Images Hercules Capital (NYSE:HTGC [https://seekingalpha.com/symbol/HTGC]) stock gained 1.4% in Thursday after-hours trading after the business development company logged reco... Full story
Yahoo Finance • 2 months ago
Emergency communications leader posts 477% YoY growth of APEX ARR; new funding to fuel cloud-native AI innovation, global expansion. NEW YORK, July 31, 2025 /PRNewswire/ -- Carbyne, the leading provider of cloud-native emergency communica... Full story
Yahoo Finance • 2 months ago
Investing.com -- Dyne Therapeutics, Inc. (NASDAQ:DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its neuromuscular disease therapies toward potential... Full story
Yahoo Finance • 3 months ago
SAN MATEO, Calif., July 17, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed... Full story
Yahoo Finance • 3 months ago
In trading on Tuesday, shares of Hercules Technology Growth Capital (Symbol: HTGC) crossed above their 200 day moving average of $19.12, changing hands as high as $19.14 per share. Hercules Technology Growth Capital shares are currently t... Full story
Yahoo Finance • 3 months ago
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 7, Luca Issi from RBC Capital maintained a Buy rating on Dyne Therapeutics, Inc. (NASDAQ:DYN) with a price target o... Full story
Yahoo Finance • 3 months ago
- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical... Full story
Yahoo Finance • 4 months ago
Hercules Capital, Inc. (NYSE:HTGC), a leader in customized debt financing for venture growth stage companies with a market capitalization of $3.09 billion, has entered into a Ninth Supplemental Indenture with U.S. Bank Trust Company, Natio... Full story
Yahoo Finance • 4 months ago
Notes due 2030 Initially Assigned a Baa3 by Moody’s Investors Service and a BBB- by Fitch Ratings, Inc. SAN MATEO, Calif., June 16, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), today announced... Full story
Yahoo Finance • 4 months ago
Savara Inc. (NASDAQ:SVRA), a biotechnology company specializing in rare respiratory diseases with a market capitalization of $466 million, is poised for a potential breakthrough with its lead candidate Molbreevi. According to InvestingPro... Full story
Yahoo Finance • 4 months ago
* Hercules Capital (NYSE:HTGC [https://seekingalpha.com/symbol/HTGC]) has priced an upsized underwritten public offering of $350M in aggregate principal amount of 6% notes due June 2030. * The closing of the transaction is subject to c... Full story